| (Values in U.S. Thousands) | Oct, 2025 | Oct, 2024 | Oct, 2023 | Oct, 2022 | Oct, 2021 |
| Sales | 6,948,000 | 6,510,000 | 6,833,000 | 6,848,000 | 6,319,000 |
| Sales Growth | +6.73% | -4.73% | -0.22% | +8.37% | +18.36% |
| Net Income | 1,303,000 | 1,289,000 | 1,240,000 | 1,254,000 | 1,210,000 |
| Net Income Growth | +1.09% | +3.95% | -1.12% | +3.64% | +68.29% |
Agilent Technologies (A)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Fiscal Year End Date: 10/31